Soleno Therapeutics Inc
CFO
2 appearances
Latest appearance 2025-11-04
James H. MacKaness
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James H. MacKaness
Earlier roles on record: CFO at Soleno Therapeutics Inc until February 26, 2026. The proxy statement of Soleno Therapeutics Inc reports total compensation of $8,774,955 for James H. MacKaness in fiscal 2024, including a base salary of $460,000. Disclosed compensation is on record for 4 fiscal years. James H. MacKaness has spoken on 2 earnings calls across 1 company, most recently for Soleno Therapeutics Inc on November 4, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Soleno Therapeutics Inc
CFO
Proxy statement
Start not stated–2026-02-26
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Soleno Therapeutics Inc | Chief Financial Officer | $460,000 | $8,774,955 |
| 2023 | Soleno Therapeutics Inc | Chief Financial Officer | $400,000 | $1,211,636 |
| 2022 | Soleno Therapeutics Inc | Chief Financial Officer | $385,000 | $626,195 |
| 2020 | Soleno Therapeutics Inc | Chief Financial Officer | $198,988 | $710,468 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Earnings call
Soleno Therapeutics Inc Q3 FY2025 Earnings Call
Soleno Therapeutics Inc
-
Earnings call
Soleno Therapeutics Inc Q2 FY2025 Earnings Call
Soleno Therapeutics Inc